FDA NDC Directory · JSON-LD · Markdown

Dapagliflozin

NDC 70771-1714 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA211582
Dosage form / routeTABLET · ORAL
Active ingredientsDAPAGLIFLOZIN (5 mg/1)
Marketing started20260406
Package count2

External sources

Source: openFDA. Public-domain (CC0).